Edition:
United States

Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

2.43DKK
4 May 2016
Change (% chg)

-- (--)
Prev Close
kr.2.43
Open
kr.2.42
Day's High
kr.2.43
Day's Low
kr.2.42
Volume
3,044
Avg. Vol
34,798
52-wk High
kr.3.37
52-wk Low
kr.2.25

NEUR.CO

Chart for NEUR.CO

About

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous... (more)
No analyst recommendations are available for NEUR.CO.

Overall

Beta: 1.55
Market Cap(Mil.): kr.59.67
Shares Outstanding(Mil.): 24.55
Dividend: --
Yield (%): --

Financials

  NEUR.CO Industry Sector
P/E (TTM): -- 63.22 44.92
EPS (TTM): -- -- --
ROI: -- 3.29 12.47
ROE: -- 4.37 13.34
Search Stocks

BRIEF-NeuroSearch: Danish Appeals Permission Board grants leave of appeal

* Says Danish Appeals Permission Board has granted company leave of appeal to Supreme Court of the judgment by Eastern Division of the Danish High Court

Mar 16 2016

BRIEF-Neurosearch FY 2016 operating loss narrows to DKK 6.5 million

* FY net loss 5.5 million Danish crowns ($810,000) versus loss 7.7 million crowns year ago

Mar 04 2016

BRIEF-NeuroSearch 9-month operating loss narrows to DKK 5 million

* 9-month net loss 4 million Danish crowns ($572,581.92) versus loss 6 million crowns year ago

Nov 19 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : GlobalData
$125.00
Provider : GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks